Stale Pre-tender

EXPRESSION OF INTEREST REQUEST. Neurodegeneration Biomarker Identification

Details

Value
EUR 340,000
Topic
Laboratory reagents
Published
24 September 2024

Tender description

EXPRESSION OF INTEREST REQUEST. St James’s Hospital have a requirement to change from current (ELISA) platform for analysis of Neurodegeneration Biomarker Identification. Expressions of interest are being sought for the following: Provision of a suitable designated benchtop platform for Neurodegeneration Biomarker identification. Vendors must be able to provide CE marked equipment and IVDR CE marked assays for quantitative measurement of Biomarkers for the following biomarkers: • Amyloid beta 1-42 (Abeta 1-42) in human cerebrospinal fluid (CSF). • Amyloid beta 1-40 (Abeta 1-40) in human cerebrospinal fluid (CSF). • Total Tau proteins in human cerebrospinal fluid (CSF). • Phospho Tau proteins in human cerebrospinal fluid (CSF). IVDR CE marking desired but not essential for the following biomarkers: • Neurofilament light (NfL) in human cerebrospinal fluid (CSF). • Phospho Tau 217 in human plasma Technical requirements for the system as listed: Continuous loading of samples. Interfacing with Abbott Analyser Management System (AMS) to receive requests and export results. Provision of support for required interfacing is essential. Please confirm your interest and capability of delivering the above scope of works. EXPRESSION OF INTEREST REQUEST. St James’s Hospital have a requirement to change from current (ELISA) platform for analysis of Neurodegeneration Biomarker Identification. Expressions of interest are being sought for the following: Provision of a suitable designated benchtop platform for Neurodegeneration Biomarker identification. Vendors must be able to provide CE marked equipment and IVDR CE marked assays for quantitative measurement of Biomarkers for the following biomarkers: • Amyloid beta 1-42 (Abeta 1-42) in human cerebrospinal fluid (CSF). • Amyloid beta 1-40 (Abeta 1-40) in human cerebrospinal fluid (CSF). • Total Tau proteins in human cerebrospinal fluid (CSF). • Phospho Tau proteins in human cerebrospinal fluid (CSF). IVDR CE marking desired but not essential for the following biomarkers: • Neurofilament light (NfL) in human cerebrospinal fluid (CSF). • Phospho Tau 217 in human plasma Technical requirements for the system as listed: Continuous loading of samples. Interfacing with Abbott Analyser Management System (AMS) to receive requests and export results. Provision of support for required interfacing is essential. Please confirm your interest and capability of delivering the above scope of works.

Timeline

  1. Completed: Pre-tender published24 September 2024
    Current notice

About the buyer

St James's Hospital is a public sector buyer in Ireland publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33696500 · Laboratory reagents
  • 38000000 · Laboratory, optical and precision equipments (excl. glasses)
  • 71900000 · Laboratory services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

20 similar open tenders

See more open tenders related to EXPRESSION OF INTEREST REQUEST. Neurodegeneration Biomarker Identification.

Explore all open tenders

Related topics

Topics related to EXPRESSION OF INTEREST REQUEST. Neurodegeneration Biomarker Identification, ranked by notice volume.

View all topics

Related buyers

Buyers similar to St James's Hospital.

View all buyers

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.